source: thevaccinereaction.org
by TVR Staff

On Sept. 19, 2019, President Donald Trump signed an Executive Order, “Modernizing Influenza Vaccines in the United State to Promote National Security and Public Health.” Describing mass use of influenza vaccines “to combat seasonal flu” and influenza pandemics as “strengthening our Nation’s public health and security,” he announced the establishment of a National Influenza Vaccine Task Force. The Task Force will develop a five-year national plan to reduce “reliance on egg-based influenza vaccine production” in the United States and increase the country’s “capacity of alternative methods” for producing influenza vaccines that “allow more agile and rapid responses to emerging influenza viruses.”¹

The Executive Order also directs the Task Force to:

• “advance the development of new, broadly protective vaccine candidates that provide more effective and longer lasting immunities;” and
• support the “promotion of increased influenza vaccine immunization” among “populations recommended” by the Centers for Disease Control and Prevention (CDC); and
• improve “public understanding of influenza risk and informed influenza vaccine decision-making.”¹

The Task Force is specifically directed to look at ways to work through the director of the CDC to “increase influenza vaccine use through enhanced communication and by removing barriers to vaccination.”¹

The Task Force will consist of a senior official from each of the following departments, agencies and offices: Department of Defense; Department of Justice; Department of Agriculture; Department of Veterans Affairs; Department of Homeland Security; Food and Drug Administration; CDC; National Institutes of Health; Centers for Medicare and Medicaid Services and the Biomedical Advanced Research and Development Authority. The Executive Order directs the Task Force to submit a report on its plan to the President within 120 days.

READ MORE HERE